Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,4,6,8-tetramethyl-2,4,6,8-tetraazabicyclo-(3.3.0)-octan-3,7-dione
2. Adaptol
3. Mebikar
1. 10095-06-4
2. Mebikar
3. 1,3,4,6-tetramethyltetrahydroimidazo[4,5-d]imidazole-2,5(1h,3h)-dione
4. Temgicoluril
5. Tetramethylglycoluril
6. Adaptol
7. 1,3,4,6-tetramethyl-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione
8. 55fe6npg89
9. Glycoluril, 1,3,4,6-tetramethyl-
10. 1,3,4,6-tetramethyl-octahydro-[1,3]diazolo[4,5-d]imidazole-2,5-dione
11. Imidazo(4,5-d)imidazole-2,5(1h,3h)-dione, Tetrahydro-1,3,4,6-tetramethyl-
12. Unii-55fe6npg89
13. Imidazo[4,5-d]imidazole-2,5(1h,3h)-dione, Tetrahydro-1,3,4,6-tetramethyl-
14. 2,4,6,8-tetramethyl-2,4,6,8-tetraazobizykl(3,3,0)oktandion-3,7 [german]
15. 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo(3.3.0)octane-3,7-dione
16. Chemdiv1_025094
17. Mebicar [who-dd]
18. Temgicoluril [inn]
19. 1,3,4,6-tetramethyltetrahydroimidazo[4,5-d]-imidazole-2,5(1h,3h)-dione
20. 2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione, 2,4,6,8-tetramethyl-
21. Tetrahydro-1,3,4,6-tetramethylimidazo(4,5-d)imidazole-2,5(1h,3h)-dione
22. Schembl1465373
23. Chembl3707390
24. Schembl14037060
25. Schembl15685069
26. Hms658e14
27. Xiuusfjtjxfngh-uhfffaoysa-
28. Dtxsid60143588
29. Chebi:136038
30. Zinc134163
31. Albb-014894
32. 2,4,6,8-tetramethyl-2,4,6,8-tetraazobizykl(3,3,0)oktandion-3,7
33. Mfcd00184215
34. Stk022918
35. 2,4,6,8-tetramethyl-2,4,6,8-tetraazabicyclo-(3.3.0)-octan-3,7-dione
36. Akos000487401
37. Db13522
38. 1,3,4,6-tetramethyl-1,3,4,6,3a,6a-hexahydro-1,3,4,6-tetraazapentalene-2,5-dion E
39. Ls-04732
40. Cs-0213579
41. Ft-0684250
42. J3.573.531c
43. D10508
44. Q4286560
45. 1,3,4,6-tetramethyl Octahydroimidazo[4,5-d]imidazolidine-2,5-dione
46. 1,3,4,6-tetramethyltetrahydroimidazo[4,5-d]imidazole-2,5(1h,3h)-dione #
47. 2,4,6,8-tetramethyl-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione
48. (1beta,5beta)-2,4,6,8-tetramethyl-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione
49. Imidazo(4,5-d)imidazole-2,5(1h,3h)-dione, Tetrahydro-1,3,4,6-tetramethyl-, Cis-
50. Imidazo[4,5-d]imidazole-2,5-(1h,3h)dione, Tetrahydro-1,3,4,6-tetramethyl-
51. 106780-29-4
| Molecular Weight | 198.22 g/mol |
|---|---|
| Molecular Formula | C8H14N4O2 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 198.11167570 g/mol |
| Monoisotopic Mass | 198.11167570 g/mol |
| Topological Polar Surface Area | 47.1 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 252 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX21 - Temgicoluril
ABOUT THIS PAGE
50
PharmaCompass offers a list of Mebicar API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mebicar manufacturer or Mebicar supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mebicar manufacturer or Mebicar supplier.
PharmaCompass also assists you with knowing the Mebicar API Price utilized in the formulation of products. Mebicar API Price is not always fixed or binding as the Mebicar Price is obtained through a variety of data sources. The Mebicar Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mebicar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mebicar, including repackagers and relabelers. The FDA regulates Mebicar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mebicar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mebicar supplier is an individual or a company that provides Mebicar active pharmaceutical ingredient (API) or Mebicar finished formulations upon request. The Mebicar suppliers may include Mebicar API manufacturers, exporters, distributors and traders.
Mebicar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mebicar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mebicar GMP manufacturer or Mebicar GMP API supplier for your needs.
A Mebicar CoA (Certificate of Analysis) is a formal document that attests to Mebicar's compliance with Mebicar specifications and serves as a tool for batch-level quality control.
Mebicar CoA mostly includes findings from lab analyses of a specific batch. For each Mebicar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mebicar may be tested according to a variety of international standards, such as European Pharmacopoeia (Mebicar EP), Mebicar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mebicar USP).
